글로벌 연구동향
핵의학
- 2022년 11월호[Korean J Radiol .] Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting 68Ga-NGUL PET/CT in Healthy Volunteers and Patients with Prostate Cancer
전립선암 PSMA 표적 68Ga-NGUL PET 1상 임상시험서울의대 / 서민석, 천기정*2022 Sep댓글: 1조회수: 784
- 2022년 11월호[Pharmaceuticals (Basel) .] A High-Affinity 64Cu-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization
성균관의대 / 박지훈, 최연성*2022 Sep 5댓글: 0조회수: 537
- 2022년 11월호[Exp Cell Res .] Current understanding of MSC-derived exosomes in the management of knee osteoarthritis
Dr.RML National Law University, 경북대/Madhan Jeyaraman, Naveen Jeyaraman*, 안병철*, , Prakash Gangadaran*2022 Sep 15댓글: 0조회수: 572
- 2022년 11월호[PLoS One .] Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
서울의대 / 이리리, 팽진철*, 이한별*2022 Sep 30댓글: 2조회수: 566
- 2022년 11월호[PLoS One .] The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy
KIRAMS / 최준호, 임일한*, 강혜진*2022 Sep 26댓글: 0조회수: 687
- 2022년 10월호[J Nucl Med.] Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection
간세포암에 대한 경동맥 방사선 색전술과 절제술의 장기적 예후에 대한 비교서울의대, 성균관의대 / 김지혜, 김주연, 이정훈*, 신동현*2022 Aug댓글: 1조회수: 660
- 2022년 10월호[Eur J Nucl Med Mol Imaging.] Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
분당서울대학교병원 / 김석, 방지인, 유수영*, 이호영*2022 Aug댓글: 1조회수: 585
- 2022년 10월호[Cancers (Basel).] Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
성균관의대 / 이현종, 최준영*2022 Aug 5댓글: 0조회수: 704
- 2022년 10월호[Cancers (Basel).] Relationship of FDG PET/CT Textural Features with the Tumor Microenvironment and Recurrence Risks in Patients with Advanced Gastric Cancers
순천향대병원, 가톨릭관동대 / 안혜인, 송금종, 이상미*, 이정원*2022 Aug 15댓글: 0조회수: 699
![[Int J Mol Sci.] Glucose-Thymidine Ratio as a Metabolism Index Using 18 F-FDG and 18 F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy](/enewspaper/upimages/1665051415admin.JPG)
2022년 10월호[Int J Mol Sci.] Glucose-Thymidine Ratio as a Metabolism Index Using 18 F-FDG and 18 F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy서울의대 / 오세라, 윤혜원*, 팽진철*2022 Aug 17댓글: 1조회수: 1328
